SCOPUS 정보 검색 플랫폼

British Journal of Clinical Pharmacology

Volumn 53, Issue 4, 2002, Pages 408-409

CYP2C9 polymorphism and warfarin dose requirements [6]

(3) Daly, Ann K a Day, Christopher P a Aithal, Guruprasad P b

a NEWCASTLE UNIVERSITY (United Kingdom)

b QUEEN S MEDICAL CENTRE (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYSTEINE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; CYTOCHROME P450 REDUCTASE; MUTANT PROTEIN; PHENYTOIN; PRIMER DNA; WARFARIN;

ACCURACY; ALLELE; AMINO ACID SUBSTITUTION; CATALYSIS; CELL LINE; DNA POLYMORPHISM; DNA SEQUENCE; DRUG METABOLISM; GENE AMPLIFICATION; GENE EXPRESSION; GENOTYPE; HUMAN; HYDROXYLATION; LETTER; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; TEMPERATURE; YEAST;

ALLELES; ANTICOAGULANTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; HETEROZYGOTE; HUMANS; POLYMORPHISM, GENETIC; STEROID 16-ALPHA-HYDROXYLASE; STEROID HYDROXYLASES; WARFARIN;

EID: 0036230088 PISSN: 03065251 EISSN: None Source Type: Journal
DOI: 10.1046/j.1365-2125.2002.01572_6.x Document Type: Letter

Times cited : (27)

References (10)

1
- 0034792584
- Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
- (2001) Br J Clin Pharmacol , vol.52 , pp. 349-355
- Goldstein, J.A.¹

2
- 0033608466
- Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications
- (1999) Lancet , vol.353 , pp. 717-719
- Aithal, G.P.¹ Day, C.P.² Kesteven, P.J.L.³ Daly, A.K.⁴

3
- 0033608176
- Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population
- (1999) Biochem Biophys Res Comm , vol.254 , pp. 628-631
- Yasar, U.¹ Eliasson, E.² Dahl, M.L.³ Johansson, I.⁴ Ingelman-Sundberg, M.⁵ Sjoqvist, F.⁶

4
- 0028861660
- Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese
- (1995) Pharmacogenetics , vol.5 , pp. 37-42
- Wang, S.-L.¹ Huang, J.-D.² Lai, M.-D.³ Tsai, J.-J.⁴

5
- 0034283762
- Influence of cytochrome P-450CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment
- (2000) Blood , vol.96 , pp. 1816-1819
- Taube, J.¹ Halsall, D.² Baglin, T.³

6
- 0027452620
- Correlation of human cytochrome P4502c substrate specificities with primary structure - Warfarin as a probe
- (1993) Mol Pharmacol , vol.43 , pp. 234-239
- Kaminsky, L.S.¹ Demorais, S.M.F.² Faletto, M.B.³ Dunbar, D.A.⁴ Goldstein, J.A.⁵

7
- 0028210729
- Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9
- (1994) Pharmacogenetics , vol.4 , pp. 39-42
- Rettie, A.E.¹ Wienkers, L.C.² Gonzalez, F.J.³ Trager, W.F.⁴ Korzekwa, K.R.⁵

8
- 0030858832
- *2 allele alters interaction of the cytochrome P450 with NADPH. cytochrome P450 oxidoreductase
- (1997) Pharmacogenetics , vol.7 , pp. 203-210
- Crespi, C.L.¹ Miller, V.P.²

9
- 0032819729
- Frequency of cytochrome P450CYP2C9 variants in a Turkish population and functional relevance for phenytoin
- (1999) Br J Clin Pharmacol , vol.48 , pp. 409-415
- Aynacioglu, A.S.¹ Brockmoller, J.² Bauer, S.³

10
- 0029798351
- Genetic analysis of the human cytochrome P450 CYP2C9 locus
- (1996) Pharmacogenetics , vol.6 , pp. 429-439
- Stubbins, M.J.¹ Harries, L.W.² Smith, G.³ Tarbit, M.H.⁴ Wolf, C.R.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.